Literature DB >> 29808333

[Update: polyarteritis nodosa].

Jan H Schirmer1, Frank Moosig2.   

Abstract

Polyarteritis nodosa (PAN) is a necrotizing arteritis of medium-sized vessels, which is often fatal if untreated. It frequently affects the skin (nodules and ulcers), the peripheral nervous system (mononeuritis multiplex) and the visceral vessels (stenoses and microaneurysms). The complex diagnostic work-up requires discriminating PAN from infectious, malignant, drug-induced and other inflammatory conditions. It can be subclassified into further variants (idiopathic, associated with hepatitis B, associated with hereditary inflammatory diseases or isolated cutaneous disease). While idiopathic and hereditary inflammatory variants require immunosuppressive treatment, the hepatitis B-associated variant is treated with virustatic agents and plasmapheresis. The isolated cutaneous variant has a good prognosis and rarely requires highly potent immunosuppressives.

Entities:  

Keywords:  Hepatitis B; Immunosuppressives; Necrotizing arteritis; Plasmapheresis; Vasculitis

Mesh:

Substances:

Year:  2018        PMID: 29808333     DOI: 10.1007/s00393-018-0469-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  50 in total

1.  Polyarteritis nodosa: spectrum of angiographic findings.

Authors:  A W Stanson; J L Friese; C M Johnson; M A McKusick; J F Breen; E A Sabater; J C Andrews
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

2.  Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Authors:  Loïc Guillevin; Alfred Mahr; Patrice Callard; Pascal Godmer; Christian Pagnoux; Emmanuelle Leray; Pascal Cohen
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

3.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

4.  Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.

Authors:  Christian Pagnoux; Thomas Quéméneur; Jacques Ninet; Elisabeth Diot; Xavier Kyndt; Benoît de Wazières; Jean-Luc Reny; Xavier Puéchal; Pierre-Yves le Berruyer; Olivier Lidove; Philippe Vanhille; Pascal Godmer; Olivier Fain; Daniel Blockmans; Boris Bienvenu; Florence Rollot; Séverine Aït el Ghaz-Poignant; Alfred Mahr; Pascal Cohen; Luc Mouthon; Elodie Perrodeau; Philippe Ravaud; Loïc Guillevin
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

5.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

6.  Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

Authors:  Loïc Guillevin; Pascal Cohen; Alfred Mahr; Jean-Pierre Arène; Luc Mouthon; Xavier Puéchal; Edouard Pertuiset; Brigitte Gilson; Mohamed Hamidou; Patricia Lanoux; Alain Bruet; Marc Ruivard; Philippe Vanhille; Jean-François Cordier
Journal:  Arthritis Rheum       Date:  2003-02-15

7.  Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa.

Authors:  Fatoş Yalçinkaya; Z Birsin Ozçakar; Ozgür Kasapçopur; Ayşenur Oztürk; Nejat Akar; Ayşin Bakkaloğlu; Nil Arisoy; Mesiha Ekim; Seza Ozen
Journal:  J Pediatr       Date:  2007-08-28       Impact factor: 4.406

8.  Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.

Authors:  L Guillevin; O Fain; F Lhote; B Jarrousse; D Le Thi Huong; A Bussel; A Leon
Journal:  Arthritis Rheum       Date:  1992-02

Review 9.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

10.  Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa.

Authors:  M C Cid; J M Grau; J Casademont; E Campo; B Coll-Vinent; A López-Soto; M Ingelmo; A Urbano-Márquez
Journal:  Arthritis Rheum       Date:  1994-07
View more
  2 in total

Review 1.  [Muscular polyarteritis nodosa-a case-based review].

Authors:  M Krusche; N Ruffer; T Kubacki; J Matschke; I Kötter
Journal:  Z Rheumatol       Date:  2019-03       Impact factor: 1.372

Review 2.  [Primary vasculitides in childhood and adulthood].

Authors:  Kirsten Minden; Jens Thiel
Journal:  Z Rheumatol       Date:  2022-01-03       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.